Articles related to Oncology, Radiation

“Controlling cancer is, of course, the goal, but there must also be a greater emphasis on life after treatment.”

Scientists discovered that just one round of exercise can change blood chemistry in breast cancer survivors, releasing proteins that help suppress tumor cell growth in laboratory experiments and pointing to exercise as a powerful, non-drug therapy.

Castalin can boost the effectiveness of CHK1 inhibitors, a class of drugs currently in phase 1 clinical trials. When tested in cellular models of triple-negative breast cancer, one of the most aggressive forms of the disease, Castalin was shown to enhance the action of these inhibitors.

These results suggest that PARP inhibition represents a potential treatment strategy in HRR-deficient advanced biliary tract cancer, including the potential platform to investigate novel combination treatment strategies as well as consideration for a more selective biomarker selection.

“Progress is sort of stepwise. How do we make things better? And what we see with FLAURA2 is that we do see an improvement in survival – a meaningful improvement in survival.” – Dr. Stephen Liu

Whether in the outpatient or the inpatient setting, pharmacists can provide key support to patients and healthcare teams… performing due diligence to confirm the desired combination of drugs based on considerations such as patient age, CBC, comprehensive metabolic panel, and drug-drug interactions.